NICE has assessed the VivaScope 1500 and 3000 (MAVIG) imaging systems for skin cancer lesions to help the NHS decide whether to use these products.

NICE has said these systems show promise but more research is needed before they can be used in the NHS.

The VivaScope 1500 and 3000 are microscopes that help a doctor to see the different layers of skin tissue and assess if a skin lesion, such as a mole, might be cancerous.

Your responsibility

This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this guidance fully into account. However, the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.

Commissioners and/or providers have a responsibility to implement the guidance, in their local context, in light of their duties to have due regard to the need to eliminate unlawful discrimination, advance equality of opportunity, and foster good relations. Nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.

  • National Institute for Health and Care Excellence (NICE)